HCP Live June 24, 2024
Study results highlight the impact of continuous glucose monitoring on glucose control and HbA1c improvements in patients with type 2 diabetes, regardless of treatment regimen.
Findings from a recent study are calling attention to the significant impact of continuous glucose monitoring (CGM) on glucose control in patients with type 2 diabetes, highlighting its impact in this patient population across individuals on various therapeutic treatments.1
The research was presented at the 84th American Diabetes Association (ADA) Scientific Sessions and found CGM use was associated with significant hemoglobin A1C (HbA1c) improvements in both non-insulin and insulin-treated patients with type 2 diabetes after 12 months.1,2
“These results suggest that CGM can play a crucial role in enhancing health outcomes for all diabetes patients,...
Today's Sponsors
Today's Sponsor